106 related articles for article (PubMed ID: 14643023)
1. Modulation of doxorubicin sensitivity by a novel organic compound, oxalyl bis (N-phenyl) hydroxamic acid on acetyl aminofluorene-induced preneoplastic hepatocytes.
Choudhuri SK; Majumder S
Cancer Lett; 2003 Dec; 202(1):25-34. PubMed ID: 14643023
[TBL] [Abstract][Full Text] [Related]
2. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
Choudhuri SK; Chatterjee A
Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
[TBL] [Abstract][Full Text] [Related]
3. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
4. A novel tin based hydroxamic acid complex induces apoptosis through redox imbalance and targets Stat3/JNK1/MMP axis to overcome drug resistance in cancer.
Banerjee K; Choudhuri SK
Free Radic Res; 2021 Oct; 55(9-10):1018-1035. PubMed ID: 34865583
[TBL] [Abstract][Full Text] [Related]
5. ROS and RNS induced apoptosis through p53 and iNOS mediated pathway by a dibasic hydroxamic acid molecule in leukemia cells.
Banerjee K; Ganguly A; Chakraborty P; Sarkar A; Singh S; Chatterjee M; Bhattacharya S; Choudhuri SK
Eur J Pharm Sci; 2014 Feb; 52():146-64. PubMed ID: 24269727
[TBL] [Abstract][Full Text] [Related]
6. Deactivation of P-glycoprotein by a novel compound, oxalyl bis (N-phenyl) hydroxamic acid.
Choudhuri SK
Neoplasma; 2002; 49(4):272-7. PubMed ID: 12382028
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes.
Lecureur V; Guillouzo A; Fardel O
Carcinogenesis; 1996 May; 17(5):1157-60. PubMed ID: 8640928
[TBL] [Abstract][Full Text] [Related]
8. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity.
Parody JP; Alvarez Mde L; Quiroga A; Ronco MT; Francés D; Carnovale C; Carrillo MC
Arch Toxicol; 2007 Aug; 81(8):565-73. PubMed ID: 17340122
[TBL] [Abstract][Full Text] [Related]
9. Strong carcinogenic stress response induction of preneoplastic cells positive for GST-P in the rat liver: Physiological mechanism for initiation.
Satoh K
Life Sci; 2018 May; 200():42-48. PubMed ID: 29501922
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
11. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro.
Hill BA; Brown PC; Preisegger KH; Silverman JA
Carcinogenesis; 1996 Mar; 17(3):451-7. PubMed ID: 8631130
[TBL] [Abstract][Full Text] [Related]
12. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes.
Chieli E; Romiti N; Cervelli F; Tongiani R
Life Sci; 1995; 57(19):1741-51. PubMed ID: 7475916
[TBL] [Abstract][Full Text] [Related]
13. Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study.
Hadjiolov N; Bitsch A; Neumann HG
Cancer Lett; 1995 Nov; 98(1):39-46. PubMed ID: 8529204
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
16. Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin.
Candussio L; Decorti G; Crivellato E; Granzotto M; Rosati A; Giraldi T; Bartoli F
Life Sci; 2002 Nov; 71(26):3109-19. PubMed ID: 12408877
[TBL] [Abstract][Full Text] [Related]
17. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
[TBL] [Abstract][Full Text] [Related]
18. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice.
Møller ME; Glowinski IB; Thorgeirsson SS
Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
Ghia M; Mereto E; Cavanna M; Brambilla G
Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
[TBL] [Abstract][Full Text] [Related]
20. Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.
Shiraki N; Hamada A; Ohmura T; Tokunaga J; Oyama N; Nakano M
Biol Pharm Bull; 2001 May; 24(5):555-7. PubMed ID: 11379779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
